PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.12%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-18.59%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-4.85%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
5.86%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
9.57%
R&D change of 9.57% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
36.75%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-5.07%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
76.74%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
5.10%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
-7.99%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
16.89%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
13.25%
D&A growth 50-75% of CRWV's 26.15%. Bruce Berkowitz would examine asset strategy.
-8.89%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
2.69%
EBITDA margin growth below 50% of CRWV's 7.69%. Michael Burry would check for structural issues.
-14.95%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-5.38%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
217.09%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-11.57%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-1.61%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-8.38%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-12.46%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-2.60%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-12.35%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-12.50%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.39%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.22%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.